Aaron Berg Sells AMRN Shares as Institutional Investors Adjust Positions

Aaron Berg, the President and CEO of AMRN, sold 3,197 shares of the company on June 26, 2026. The shares were sold at an average price of $16.35, bringing the total transaction value to $52,270.95. This transaction was not part of a pre-planned trading program.

Other Institutional Activity in AMRN

Several institutional investors have recently adjusted their positions in AMRN. Sarissa Capital Management maintained its holdings with 1,673,395 shares valued at about $24.2 million. Acadian Asset Management increased its stake by 56,327 shares, resulting in 636,769 shares worth approximately $9.18 million, a 9.7% increase. Kynam Capital Management added 83,109 shares to hold a total of 472,382 shares, valued at $6.83 million, marking a 21.3% increase. Millennium Management significantly boosted its position by 134,301 shares, now holding 300,536 shares worth $4.35 million, an 80.8% increase. On the other hand, Morgan Stanley reduced its holdings by 36,937 shares, ending with 293,172 shares valued at $4.24 million, an 11.2% decrease.

Amarin Corporation plc Stock Up 14.7%

Shares of AMRN traded near $15.92 on Wednesday. The stock has experienced fluctuations, with a 52-week low of $4.00 and a high of $19.50. AMRN's 50-day moving average is $14.50, while the 200-day moving average stands at $12.75. The company's financial metrics, such as market cap and P/E ratio, were not provided.

Insider Buying and Selling at Amarin Corporation plc

In addition to Aaron Berg's sale, there were other insider transactions at AMRN. On the same day, June 26, 2026, Aaron Berg also bought 6,250 shares, indicating varied trading activity. Another insider, Patrice Eadon Bonfiglio, sold 403 shares at $14.98 on April 18, 2026, and purchased 838 shares on the same day.

Analysts Set New Price Targets

Analysts have been active in setting price targets for AMRN. On June 25, 2025, Goldman Sachs maintained its 'sell' rating with a price target of $12.00. The consensus among analysts is cautious, with varied recommendations and target prices.

Bottom Line

Aaron Berg's recent sale of AMRN shares comes amid various institutional adjustments, reflecting ongoing interest in the company's stock. While insider selling can sometimes raise questions, it doesn't necessarily indicate a lack of confidence. Investors and analysts continue to closely watch AMRN, as evidenced by the recent activity and price target updates. Remember, insider transactions and institutional filings are historical and may not reflect current sentiment.